Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Aceso Life Science Group Limited
  6. News
  7. Summary
    474   KYG0070S1066

ACESO LIFE SCIENCE GROUP LIMITED

(474)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Hao Tian Development Group Limited Announces Board Appointments

08/18/2020 | 07:46am EST

Hao Tian Development Group Limited announced that Dr. Wang Yu and Dr. Li Yao have been appointed as non-executive Directors with effect from 18 August 2020. Dr. Wang, aged 62, has extensive connection and possesses decades of experience in the healthcare space in the People's Republic of China. He is a highly recognized scholar who previously served as the director of Institute of Hepatology, Peking University Health Science Center (formerly known as Beijing Medical University). Dr. Li, aged 51, has over 25 years of experience in financial industry. He has been working for International Finance Corporate of World Bank Group since 1999 and he currently is the Regional Chief Investment Officer for East Asia and Pacific of IFC. Dr. Li also serves as an independent director of 21Vianet Group Inc.


© S&P Capital IQ 2020
All news about ACESO LIFE SCIENCE GROUP LIMITED
2021Aceso Life Science Group Limited Announces Changes in Composition of the Nomination Com..
CI
2021Aceso Life Science Sees Fiscal H1 Attributable Loss Drop
MT
2021Aceso Life Science Group Limited Reports Earnings Results for the Half Year Ended Septe..
CI
2021Aceso Life Science Group Limited Announces Resignation of Wang Yu as Non-Executive Dire..
CI
2021ACESO LIFE SCIENCE : Selling Stake Worth Nearly $43 Million in Hao Tian International
MT
2021Fong, Tim entered into the Sale and Purchase Agreement to acquire 8.44% stake in Hao Ti..
CI
2021Aceso Life Science Group Limited Announces Executive Changes
CI
2021Aceso Life Science Group Limited Announces Resignation of Li Yao as Non-Executive Direc..
CI
2021Aceso Life Science Group Limited Reports Consolidated Earnings Result for the Year Ende..
CI
2021ACESO LIFE SCIENCE : Supplemental joint announcement discloseable transaction in relation ..
PU
More news
Financials
Sales 2021 98,0 M 12,6 M 12,6 M
Net income 2021 -376 M -48,3 M -48,3 M
Net Debt 2021 2 086 M 268 M 268 M
P/E ratio 2021 -3,59x
Yield 2021 -
Capitalization 1 374 M 176 M 176 M
EV / Sales 2020 -120x
EV / Sales 2021 37,3x
Nbr of Employees 167
Free-Float 37,2%
Chart ACESO LIFE SCIENCE GROUP LIMITED
Duration : Period :
Aceso Life Science Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACESO LIFE SCIENCE GROUP LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Managers and Directors
Chi Tak Fok Chief Financial Officer & Executive Director
Ming Sun Chan Independent Non-Executive Director
Kwan Sing Lam Independent Non-Executive Director
Yiu Tong Mak Independent Non-Executive Director
Hai Ying Xu Executive Director
Sector and Competitors